Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From StemoniX Inc.
New company licenses obicetrapib from Amgen after previous companies’ setbacks in CETP class and works with FDA on a Phase III protocol. BMS buys protein-engineering specialist Forbius.
Gene-editing focused start-ups Beam Therapeutics, Gracell, Snipr Biome and Precision Biosciences raised a total of $310m in financings in February and March. For other recent venture funding deals...
In Vitro Diagnostics
- Chemistry, Immunoassay
- Drug Discovery Tools